Specifications Manual for Joint Commission National Quality Measures (v2018A)
Home » Aldosterone Receptor Antagonist Prescribed for LVSD in the Outpatient Setting

Release Notes:
Data Element
Version 2018A

Data Element Name: Aldosterone Receptor Antagonist Prescribed for LVSD in the Outpatient Setting
Collected For: ACHFOP-03
Definition:Documentation that aldosterone receptor antagonist was prescribed for LVSD in the outpatient setting. The main action of aldosterone is to increase sodium re-absorption by the kidneys. At the same time it increases the excretion of hydrogen and potassium ions. Aldosterone receptor antagonists block the effects of aldosterone, therefore decreasing sodium re-absorption and water retention by the kidneys and consequently lead to a decrease in blood pressure. Aldosterone receptor antagonists are used to treat hypertension.
Suggested Data Collection Question:Was an aldosterone receptor antagonist prescribed for LVSD in the outpatient setting?
Format:
Length:1
Type:Alphanumeric
Occurs:1
Allowable Values:

Y (Yes) An aldosterone receptor antagonist was prescribed for LVSD in the outpatient setting, or the patient is currently on this medication.

N (No) An aldosterone receptor antagonist was not prescribed for LVSD in the outpatient setting or unable to determine from medical record documentation.
Notes for Abstraction:
  • All medication documentation available in the chart should be reviewed and taken into account by the abstractor.
  • If the patient is currently on an aldosterone receptor antagonist, answer “Yes”.
  • If the patient does not have LVSD or an ejection fraction <40%, select "No".
Suggested Data Sources:

  • Discharge summary
  • Discharge instruction sheet
  • Outpatient medical record
Additional Notes:
Guidelines for Abstraction:
Inclusion Exclusion
  • Spironolactone
  • Eplerenone

All other aldosterone receptor antagonist medications other than those listed as inclusions.

Aldosterone Receptor Antagonist Prescribed for LVSD in the Outpatient Setting
Specifications Manual for Joint Commission National Quality Measures (v2018A)
Discharges 07-01-18 (3Q18) through 12-31-18 (4Q18)
^